The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2011

Filed:

Sep. 22, 2005
Applicants:

Ira Pastan, Potomac, MD (US);

Tomoko Ise, Rockville, MD (US);

Laiman Xiang, Fairfax, VA (US);

Satoshi Nagata, Rockville, MD (US);

Inventors:

Ira Pastan, Potomac, MD (US);

Tomoko Ise, Rockville, MD (US);

Laiman Xiang, Fairfax, VA (US);

Satoshi Nagata, Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C12P 21/08 (2006.01); C12Q 1/00 (2006.01); G01N 33/53 (2006.01); C12N 5/02 (2006.01); C12N 5/06 (2006.01); C07K 17/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Antibodies that specifically bind the extracellular domain of IRTA2 are disclosed herein. In one embodiment, these antibodies do not specifically bind IRTA1, IRTA3, IRTA4, or IRTA5. In one example, the antibodies are humanized antibodies. The antibodies can be conjugated to effector molecules, including detectable labels, radionucleotides, toxins and chemotherapeutic agents. The antibodies that specifically bind IRTA2 are of use to detect B cell malignancies, such as hairy cell leukemia and non-Hodgkin's lymphoma. These antibodies that specifically bind IRTA2 are also of use to treat B cell malignancies that express IRTA2, such as hairy cell leukemia and non-Hodgkin's lymphoma.


Find Patent Forward Citations

Loading…